Cerus Corporation (CERS) is a Healthcare · Medical Devices company listed on NASDAQ. Price $2.66 (+0.00%), Market cap $0.54B, 52-week low–high $1.16 ~ $2.74.
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INT
Financial statements, price targets, institutional (13F) holdings and related news for Cerus Corporation are updated in real time on BlackAll Trade.
Cerus Corporation trades at $2.66 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Cerus Corporation has a market cap of about $0.54B.
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Bloo